Xikang Cloud Hospital Holdings (9686) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
15 Oct, 2026Executive summary
Revenue contracted as the business mix shifted away from smart healthcare products; gross margin improved and the annual loss narrowed.
Medical services grew, led by home care and health management; platforms expanded across provincial and municipal markets.
Financial highlights
FY2023 revenue fell 21.8% YoY to RMB537.7m; gross profit decreased 2.3% to RMB164.6m.
Gross margin rose 6.1 percentage points to 30.6%; loss for the year narrowed 36.3% to RMB154.9m.
Adjusted net loss, excluding share-based compensation and redeemable-rights interest, narrowed to RMB115.4m from RMB146.9m.
Outlook and guidance
2024 priorities include optimizing the business mix, pursuing cost savings and profit growth, and improving platform functionality through productization, digitalization and AI.
Plans include integrating online and offline medical services, expanding home care, strengthening corporate health management, and linking healthcare products with services.
Latest events from Xikang Cloud Hospital Holdings
- Revenue declined, but adjusted loss narrowed sharply as nursing services scaled.9686
H2 2025 - Health management gains lifted margins as product sales slumped and losses narrowed.9686
H1 2023 - Nursing growth and cost controls narrowed losses as H1 revenue fell 18.1%.9686
H1 2024 - Nursing growth and lower costs narrowed H1 losses as revenue rose 2.4%.9686
H1 2026 - Loss narrowed and operating cash flow turned positive as home-care services scaled.9686
H2 2024 - Nursing and health management growth narrowed losses as medical services weakened.9686
H1 2025